Kytopen

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a cell engineering platform designed to offer healthy and functional cells. Kytopen is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $47 million in Sep 2024. It has raised $52.9 million across 5 recorded rounds; the latest was a $7.1 million early-stage round in Feb 2025.

Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$52.9M
Last round
Early Stage VC
Feb 2025
Cap table — not yet on record

Kytopen's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kytopen with a free account
  • ·The complete investor list: 16 names
  • ·Watch Kytopen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Kytopen

Where does Kytopen's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kytopen's 5 recorded funding rounds.